Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL5423043 | 0.94 | — | — | |
| Bicarbonate SCHEMBL15546678 | 0.94 | — | — | |
| Bicarbonate SCHEMBL931293 | 0.94 | — | — | |
| Bicarbonate SCHEMBL456119 | 0.94 | — | — | |
| Bicarbonate SCHEMBL7174903 | 0.94 | CA4 (0.42) | — | |
| Bicarbonate SCHEMBL19664202 | 0.94 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL5140516 | 0.94 | — | — | |
| Bicarbonate SCHEMBL15863774 | 0.94 | — | — | |
| Bicarbonate SCHEMBL21331688 | 0.94 | — | — | |
| Bicarbonate SCHEMBL18862 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218551-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | ABERGAVENNY NV (BE) | 2023-07-13 | — | — | US | disclosed |
| US-20230201141-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | ABERGAVENNY NV (BE) | 2023-06-29 | — | — | US | disclosed |
| US-11642322-B2 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | ABERGAVENNY NV (BE) | 2023-05-09 | — | — | US | disclosed |
| US-11007159-B2 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | ABERGAVENNY NV (BE) | 2021-05-18 | — | — | US | disclosed |
| US-20190117594-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | ABERGAVENNY NV (BE) | 2019-04-25 | — | — | US | disclosed |
| WO-2017187335-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | ABERGAVENNY NV (BE) | 2017-11-02 | — | — | WO | disclosed |
| US-20130039846-A1 | METHOD FOR PRODUCING HYDROGEN | FUKAI TOSHIHARU (JP) | 2013-02-14 | — | — | US | disclosed |
| EP-1537091-B1 | NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS | HOFFMANN LA ROCHE (CH) | 2010-10-06 | — | — | EP | disclosed |
| EP-1537091-A1 | NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS | F.HOFFMANN-LA ROCHE AG (CH) | 2005-06-08 | — | — | EP | disclosed |
| US-6809110-B2 | NONINSULIN DEPENDENT DIABETES; SUCH AS 2-ETHOXY-3-(4-(2-(5-METHYL-2-PHENYL-THIAZOL-4-YL)-ETHOXY)-BENZO(B)THIOPHEN-7-YL)-PROPIONIC ACID | HOFFMANN-LA ROCHE INC. | 2004-10-26 | — | — | US | disclosed |
| US-20040110807-A1 | Thiazole derivatives | HOFFMANN-LA ROCHE INC. | 2004-06-10 | — | — | US | disclosed |
| WO-2004020420-A1 | NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS | F.HOFFMANN-LA ROCHE AG (CH) | 2004-03-11 | — | — | WO | disclosed |